---
schema_version: "secwatch.filing_event.v1"
accession: "0001023024-25-000074"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:07:19.189764+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# ANI Pharma announces NEW DAY clinical trial results; no specifics in filing

## Summary
- Filed Item 8.01 with press release and conference call on NEW DAY Study results.
- Presentation attached as Exhibit 99.1; data not reproduced in the 8-K text.
- No revenue, EPS, or numeric endpoints provided in the filing body.
- Investors should review the full presentation for study outcomes.

## SEC filing metadata
- accession: 0001023024-25-000074
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000074/0001023024-25-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000074/ani-20250723.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001023024-25-000074
- JSON: https://secwatch.observer/filing/0001023024-25-000074.json
- Plain text: https://secwatch.observer/filing/0001023024-25-000074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.